Christopher Willy Schwarz

6PUBLICATIONS
18CO-AUTHORS
Behavioural epidemiologyAllergyGene and molecular therapyPredictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 14, 2026
Steatotic liver disease in patients with hidradenitis suppurativa: A prospective study.

|Aug 18, 2025
Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors.

Christopher Willy Schwarz, Charlotte Näslund-Koch, Claus Zachariae

|May 06, 2025
Real-world experience of multiple switches between adalimumab biosimilars in patients with psoriasis.

Ole Krogh-Jensen, Christopher Willy Schwarz, Diljit Kaur-Knudsen

|Sep 20, 2024
Characteristics of Patients With Psoriasis Treated With Various Biologics - A Danish Cohort Study.

Christopher Willy Schwarz, Lone Skov, Alexander Egeberg

|Jun 06, 2023
Adalimumab does not cause weight gain in patients with psoriasis in the first year of treatment.

Christopher W Schwarz, Nikolai Loft, Diljit Kaur-Knudsen

|May 24, 2023
Urinary tract infections in Danish patients with psoriasis initiating their first biological treatment.

Morten Bahrt Haulrig, Nikolai Loft, Christopher Willy Schwarz

Pageof 1

Frequent Collaborators

6 joint publications

Lone Skov

5 joint publications

Nikolai Loft

2 joint publications

Claus Zachariae

2 joint publications

Simon Francis Thomsen